Inhibition of IL-2-induced proliferation of CD20+, CD4+, and CD8+ cells was maximal with 243 μM SIL and plateaued with higher doses (Figure 3E). This evidence concerns the gene IL2 and squamous cell intraepithelial neoplasia.